These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 36660710)
1. Prognostic analysis of Li D; Fan X; Zuo L; Wu X; Wu Y; Zhang Y; Zou F; Sun Z; Zhang W Ann Transl Med; 2022 Dec; 10(24):1356. PubMed ID: 36660710 [TBL] [Abstract][Full Text] [Related]
2. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
3. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S Front Genet; 2022; 13():906496. PubMed ID: 35938009 [TBL] [Abstract][Full Text] [Related]
5. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H Front Genet; 2021; 12():785185. PubMed ID: 34917132 [No Abstract] [Full Text] [Related]
6. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma. Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y Front Genet; 2021; 12():682082. PubMed ID: 34745200 [No Abstract] [Full Text] [Related]
7. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. Zhang Z; Wang J; Han W; Zhao L BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402 [TBL] [Abstract][Full Text] [Related]
8. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis. Wang R; Hu X; Liu X; Bai L; Gu J; Li Q PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma. Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578 [TBL] [Abstract][Full Text] [Related]
10. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051 [TBL] [Abstract][Full Text] [Related]
11. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility. Liu Y; Meng J; Ruan X; Wei F; Zhang F; Qin X Sci Rep; 2024 Jan; 14(1):746. PubMed ID: 38185671 [TBL] [Abstract][Full Text] [Related]
12. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL Front Genet; 2022; 13():930446. PubMed ID: 36110218 [No Abstract] [Full Text] [Related]
13. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
14. A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma. Wang L; Wang Q; Li Y; Qi X; Fan X J Gene Med; 2024 Jan; 26(1):e3588. PubMed ID: 37715643 [TBL] [Abstract][Full Text] [Related]
15. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma. Yuan W; Xiao JH; Zhang JS; Mao BL; Wang PZ; Wang BL Front Oncol; 2023; 13():1153353. PubMed ID: 37056336 [TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma. Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma. Kong R; Wang N; Zhou CL; Lu J J Microbiol Biotechnol; 2024 Apr; 34(4):958-968. PubMed ID: 38494878 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
19. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma. Yue Y; Tao J; An D; Shi L Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of N Zhu HX; Lu WJ; Zhu WP; Yu S J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]